{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Diskus", "query": { "intervention": "Diskus" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 89, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Diskus&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T14:26:48.920Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02433834", "title": "Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Glycopyrronium MDI", "type": "DRUG" }, { "name": "Serevent Diskus 50 μg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pearl Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 248, "start_date": "2015-05-27", "completion_date": "2016-03-26", "has_results": true, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-09-03T14:26:48.920Z", "location_count": 43, "location_summary": "Birmingham, Alabama • Anaheim, California • Bakersfield, California + 36 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Bakersfield", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02433834" }, { "nct_id": "NCT03240575", "title": "The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Tiotropium", "type": "DRUG" }, { "name": "Olodaterol", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 302, "start_date": "2017-08-14", "completion_date": "2019-05-06", "has_results": true, "last_update_posted_date": "2020-04-16", "last_synced_at": "2026-09-03T14:26:48.920Z", "location_count": 45, "location_summary": "Jasper, Alabama • Flagstaff, Arizona • Fullerton, California + 40 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Flagstaff", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Northridge", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03240575" }, { "nct_id": "NCT00235053", "title": "Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma", "Candidiasis, Oral", "Voice Disorders" ], "interventions": [ { "name": "fluticasone/salmeterol DISKUS 250/50", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergy & Asthma Medical Group & Research Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 13, "start_date": "2005-08", "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2024-01-30", "last_synced_at": "2026-09-03T14:26:48.920Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00235053" }, { "nct_id": "NCT02730351", "title": "Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone furoate/ Vilanterol 100 mcg/25 mcg", "type": "DRUG" }, { "name": "Fluticasone propionate 250 mcg", "type": "DRUG" }, { "name": "Placebo via ELLIPTA inhaler", "type": "DRUG" }, { "name": "Placebo via DISKUS / ACCUHALER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "12 Years to 50 Years" }, "enrollment_count": 75, "start_date": "2016-05-25", "completion_date": "2017-02-03", "has_results": true, "last_update_posted_date": "2019-07-16", "last_synced_at": "2026-09-03T14:26:48.920Z", "location_count": 13, "location_summary": "Huntington Beach, California • Los Angeles, California • San Diego, California + 9 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02730351" }, { "nct_id": "NCT00565266", "title": "Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "tiotropium bromide", "type": "DRUG" }, { "name": "salmeterol xinafoate", "type": "DRUG" }, { "name": "beclomethasone dipropionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 210, "start_date": "2008-05", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-09-03T14:26:48.920Z", "location_count": 10, "location_summary": "San Diego, California • San Francisco, California • Denver, Colorado + 7 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00565266" }, { "nct_id": "NCT02245672", "title": "MGR001 / Advair Diskus Local Equivalence Study in Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)", "type": "DRUG" }, { "name": "Advair (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharma UK Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1128, "start_date": "2014-10", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2022-02-24", "last_synced_at": "2026-09-03T14:26:48.920Z", "location_count": 101, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Anaheim, California + 84 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Bakersfield", "state": "California" }, { "city": "Burbank", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02245672" }, { "nct_id": "NCT03543176", "title": "Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "UMEC/VI", "type": "OTHER" }, { "name": "FLUT/SAL", "type": "OTHER" }, { "name": "CAT", "type": "OTHER" }, { "name": "mMRC", "type": "OTHER" }, { "name": "Ellipta", "type": "DEVICE" }, { "name": "Diskus", "type": "DEVICE" } ], "intervention_types": [ "OTHER", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 789, "start_date": "2018-05-31", "completion_date": "2019-08-21", "has_results": true, "last_update_posted_date": "2020-08-05", "last_synced_at": "2026-09-03T14:26:48.920Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03543176" }, { "nct_id": "NCT00118690", "title": "A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bronchospasm", "Activity/Exercise Induced Bronchospasm" ], "interventions": [ { "name": "Fluticasone propionate/salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "4 Years to 17 Years" }, "enrollment_count": 227, "start_date": "2003-12", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2016-09-23", "last_synced_at": "2026-09-03T14:26:48.920Z", "location_count": 51, "location_summary": "Jonesboro, Arkansas • East Artesia, California • Huntington Beach, California + 45 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "East Artesia", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00118690" }, { "nct_id": "NCT00605891", "title": "Dose Finding Study of CHF 4226 for Treating Patients With COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "carmoterol (CHF 4226)", "type": "DRUG" }, { "name": "salmeterol", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Chiesi Farmaceutici S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 278, "start_date": "2006-10", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2017-04-11", "last_synced_at": "2026-09-03T14:26:48.920Z", "location_count": 24, "location_summary": "Jonesboro, Arkansas • Fresno, California • San Diego, California + 19 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00605891" }, { "nct_id": "NCT00071552", "title": "Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Qvar", "type": "DRUG" }, { "name": "Flovent Diskus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "12 Years to 70 Years" }, "enrollment_count": 49, "start_date": "2004-01-31", "completion_date": "2006-07-31", "has_results": false, "last_update_posted_date": "2021-11-24", "last_synced_at": "2026-09-03T14:26:48.920Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00071552" } ] }